Quince Therapeutics Inc.
1.76
0.05 (2.92%)
At close: Jan 15, 2025, 3:59 PM
1.76
0.00%
After-hours Jan 15, 2025, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 322.00K 175.00K 344.00K 332.00K 188.00K 51.00K 45.00K
Gross Profit -322.00K -175.00K -344.00K -332.00K -188.00K -51.00K -45.00K
Operating Income -34.62M -52.02M -90.32M -78.89M -39.17M -12.12M -10.37M
Interest Income 3.48M 1.07M 620.00K 2.04M 2.19M 806.00K n/a
Pretax Income -31.58M -51.94M -89.94M -76.85M -36.98M -12.48M -12.23M
Net Income -31.39M -51.66M -89.33M -76.85M -36.79M -12.48M -12.23M
Selling & General & Admin 15.39M 26.01M 29.52M 17.59M 8.95M 2.03M 1.27M
Research & Development 9.45M 25.18M 60.80M 61.31M 30.21M 10.09M 9.10M
Other Expenses 9.78M -997.00K -247.00K n/a n/a n/a n/a
Operating Expenses 34.62M 51.19M 90.32M 78.89M 39.17M 12.12M 10.37M
Interest Expense n/a 568.00K n/a n/a n/a 957.00K 1.64M
Selling & Marketing Expenses -2.30M n/a n/a n/a n/a n/a n/a
Cost & Expenses 34.62M 51.19M 90.32M 78.89M 39.17M 12.12M 10.37M
Income Tax -197.00K -284.00K -620.00K 2.17M -188.00K 357.00K 1.86M
Shares Outstanding (Basic) 37.24M 33.50M 29.72M 29.18M 19.03M 21.55M 21.55M
Shares Outstanding (Diluted) 37.24M 33.50M 29.72M 29.18M 19.03M 21.55M 21.55M
EPS (Basic) -0.84 -1.54 -3.01 -2.63 -1.93 -0.58 -0.57
EPS (Diluted) -0.84 -1.54 -3.01 -2.63 -1.93 -0.58 -0.57
EBITDA -31.26M -52.02M -89.97M -78.56M -38.98M -12.07M -10.32M
Depreciation & Amortization 322.00K 175.00K 344.00K 332.00K 188.00K 51.00K 45.00K

Create Price Alert on QNCX

Your price alert will notify you when the stock price is above 1.76.

Add to Watchlist